Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity

The safety and feasibility of dendritic cell (DC)-based immunotherapies in cancer management have been well documented after more than twenty-five years of experimentation, and, by now, undeniably accepted. On the other hand, it is equally evident that DC-based vaccination as monotherapy did not ach...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	María Julia Lamberti, Annunziata Nigro, Fátima María Mentucci, Natalia Belén Rumie Vittar, Vincenzo Casolaro, Jessica Dal Col
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	MDPI AG 2020-03-01
श्रृंखला:	Pharmaceutics
विषय:	immunogenic cell death dendritic cell-based vaccination immunotherapy cancer treatment
ऑनलाइन पहुंच:	https://www.mdpi.com/1999-4923/12/3/256
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!